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Abstract
Purpose Although most in vitro studies indicate that
collagen is a suitable biomaterial for tendon and ligament
tissue engineering, in vivo studies of implanted collagen
for regeneration of these tissues are still lacking. The
objectives of this study were the following: (1) to
investigate the regeneration of the central third of the
ovine patellar tendon using implants made of an open
array of collagen fibres (reconstituted, extruded bovine
collagen); and (2) to compare two collagen crosslinking
chemistries: carbodiimide and carbodiimide associated
with ethyleneglycoldiglycidylether.
Methods Forty-eight Welsh Mountain sheep were operated
on their right hind leg. The central third of patellar tendon was
removed and substituted with carbodiimide (n = 16) and car-
bodiimide–ethyleneglycoldiglycidylether-crosslinked implants
(n = 16). In the control group the defect was left empty
(n = 16). The central third of contralateral unoperated tendons
was used as positive controls. Half of the sheep in each group
were killed at 3- and 6-month time points. After proper
dissection, tendon sub-units (medial, central and lateral)
were tested to failure (n = 6 for each group), whilst 2 non-
dissected samples were used for histology.
Results Both the implants had significantly lower stress to
failure and modulus with respect to native tendon at both
3- and at 6-month time points. The implants did not statis-
tically differ in stress to failure, whilst carbodiimide-cross-
linked implants had significantly higher modulus than
carbodiimide–ethyleneglycoldiglycidylether-crosslinked
implants both at 3 and at 6 months. Histology showed
carbodiimide-crosslinked implants to have a better integration
with the native tendon than carbodiimide–ethyleneglycoldigly-
cidylether-crosslinked implants. Carbodiimide-crosslinked
implants appeared partially resorbed and showed increased
tissue ingrowth with respect to carbodiimide–ethylenegly-
coldiglycidylether-crosslinked implants.
Conclusions To deliver collagen implants as an open
array of fibres allows optimal tendon–implant integration
and good ingrowth of regenerated tissue. In the present
study the resorption rate of both the examined implants was
too low due to the high level of crosslinking. This led to
only minor substitution of the implant with regenerated
tissue, which in turn produced a low-strength implanted
region. Further studies are needed to find the right balance
between strength and resorption rate of collagen fibres.
Keywords Tissue engineering  Collagen fibre 
Augmentation  Collagen crosslinking  Tendon repair
Introduction
Tendon and ligament injuries often result in large tissue
gaps requiring appropriate grafting to augment or substitute
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the injured tissue and restore natural function [2, 18, 21, 24,
27]. However, autografting, allografting and synthetic
grafting all suffer specific complications such as donor site
morbidity [29], immunoreaction [28] and fatigue tearing
[31]. Consequently, an off-the-shelf, resorbable scaffold
capable of withstanding load and able to progressively
regenerate native tissue would be a useful treatment option
in selected cases.
Collagen scaffolds have been widely studied both in
vitro and in vivo in an attempt to regenerate tendon and
ligament tissue [5, 7, 12]. Collagen fibres included in a
collagen matrix have been adopted to regenerate the
anterior cruciate ligament (ACL) in a dog model and the
Achilles tendon in a rat model [9, 15]. However, collagen
fibres arranged in an open array have never been implanted
in a large animal model.
Reconstituted collagen fibres are weak and degrade very
quickly even in in vitro culture conditions [4]. Therefore,
crosslinking chemistry is the main factor capable of influ-
encing collagen fibre strength and resorption rate. Many
physical and chemical crosslinking methods have been
explored [16]; however, to date the optimal compromise
between strength, biocompatibility and resorption rate has not
been found. Recently, the association of carbodiimide (EDC)
with an epoxy compound (EGDE) has gained interest as a
novel collagen crosslinking chemistry capable of yielding
strong collagen with good biocompatibility [33].
It has been found that a single EDC/EGDE fibre could
resist stresses of more than 10 MPa [10], which is thought
to be the amount of load a human ACL withstands during
normal daily activities [25].
This study has been conceived to develop a resorbable
collagen implant for tendon and ligament biological aug-
mentation. This study aimed to (1) evaluate the tissue
regeneration potential of an EDC-crosslinked open array of
collagen fibres implanted in the central third of sheep
patellar tendon; and (2) compare the EDC crosslinking
chemistry with the novel EDC/EGDE crosslinking chem-
istry in terms of mechanical properties and tissue
integration.
Materials and methods
Implant manufacturing
Acid-swollen type-I collagen from bovine corium was
dispersed at 6 mg mL-1 in 2 mM HCl for at least 15 h,
blended and then degassed at 20 mTorr and stored in
30-mL syringes at 4 C for up to 2 weeks.
The collagen gel was extruded from an 0.51-mm
microbore tubing at 0.3 mL min-1 using a syringe pump
(Chemxy fusion 200, KR Analytical, Cheshire, UK) into a
stainless steel bath containing ‘‘fibre formation buffer’’
(FFB), which consisted of phosphate-buffered saline (PBS)
and 20 % w/v poly(ethylene glycol) (PEG) Mw * 8000
(Sigma-Aldrich, Dorset, UK) at 37 C. The fibre was
incubated for at least 5 min in FFB to allow coagulation
and partial fibrillogenesis to occur.
The fibre was then wound onto a spool using a custom-
built automated system that utilized a rotating and trans-
lating spool. The individual fibres were visible in the final
dried assembly (Fig. 1a).
The dried collagen/PEG composite was simultaneously
crosslinked and washed on the spool in an 80 % acetone/
water solution. The assembly was then crosslinked in
either: (1) a solution of 25 mM EDC and 12.5 mM
N-hydroxysuccinimide NHS in 80 % acetone/PBS for 2 h
or (2) a solution of 25 mM EDC and 12.5 mM NHS in
80 % acetone/PBS for 2 h followed by incubation in a
solution of 1 % (v/v) ethyleneglycoldiglycidylether
(EGDE) in PBS for 5 days.
After crosslinking, the assembly was washed on the
spool with PBS for 2 9 30 min and ultra-high-purity
water (R [ 18 MX) for 2 9 30 min. The hydrated and
crosslinked assembly was then air dried overnight.
Removal of PEG was confirmed via both differential
scanning calorimetry and Fourier transform infrared
spectroscopy in comparison with unwashed controls (data
not shown). The dried assembly was then sterilized using
c-irradiation at 25 kGy. The end product is shown in
Fig. 1.
Fig. 1 a Dehydrated collagen fibre implant; b hydrated implant under tension
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Surgical technique
Operations were carried out on forty-eight Welsh Mountain
sheep aged between 3 and 5 years and weighing 30–50 kg.
There were 3 operative groups (EDC implants, EDC/
EGDE implants and empty controls) and 2 time points
(3 and 6 months). Under general anaesthesia, the sheep
right leg was clipped and hair was removed with a wet
cloth. Scaffold implantation was performed under strictly
aseptic conditions (Fig. 2). A knee midline skin incision
was performed, and the paratenon was incised and pre-
served. A double-bladed knife (blades 4 mm apart) was
used to remove the central third of the patellar tendon. Two
drill holes of 4 mm ø and 5 mm depth were made in the
tibial tuberosity and in the patella at the bone–tendon
junction. Through K-wire holes, 3–0 nylon sutures were
passed within the 4-mm ø drill holes and used to fix the
hydrated implant in place under tension. Three 4–0 silk
sutures were placed on each side of the implant on the
normal tendon tissue to identify the boundary between the
implant and the remnants. All animals were allowed to
move freely without immobilization after surgery. Post-
operatively, sheep were kept inside in small groups for
2 days and then moved to larger pens in community. For
the majority of the experimental period, they were allowed
free access to open-field grazing. Sheep were killed at 3
and 6 months after surgery. The hind knee joints were
immediately dissected and kept at -80 C.
Mechanical testing
Six specimens from each group were used for mechanical
testing. Immediately after killing, the patella–patellar ten-
don–tibial tuberosity complex was isolated from each knee
(right and left). In the right knee (treated), all the scar tissue
surrounding the tendon was removed, the implant (or the
regenerated tissue in the empty defect) was identified and
separated from the two remnants, and the patella was
sawed so as to obtain two patella–tendon–tibia units
(medial and lateral) and a central patella–implant/regen-
erated tibia unit (Fig. 3c, e). In the left knee (control), the
patella–tendon–tibial tuberosity complex was isolated, the
double-blade knife was used to separate the central third of
the patellar tendon, and the patella was sawed to obtain
three patella–tendon–tibia units. After dissection, samples
were stored at -80 C.
Before mechanical testing, samples were allowed to
defrost overnight at room temperature in glass jars con-
taining deionized water. The cross-sectional areas of the
tendons were measured using vernier callipers at 4 loca-
tions, at equal spacing from the top to the bottom of the
tendons. Bone blocks were gripped using grips with ser-
rated faces. The bottom bone block was held at an angle of
20 using custom-made grips to ensure that all tendon
fibres were loaded simultaneously. The mechanical test
setting is shown in Fig. 3g and h. Mechanical testing was
carried out using an ESH mechanical testing machine fitted
with a 10 kN load cell (accuracy 0.1 N). A program was
written to control and run the tests automatically.
For each sample, the first third to be tested was always
the central third, followed by the lateral third and finally
the medial third. Whilst one section of tendon was being
tested, the remaining parts were kept wrapped in wet sur-
gical cloth, and a mister was used during testing to ensure
that samples remained fully hydrated.
The mechanical testing procedure used was as follows:
(1) a small preload of 1 N was applied; (2) a preconditioning
step was carried out, in which 10 cycles from 0 to 1 % strain
were performed at a rate of 0.5 Hz; (3) the load was removed
and the sample was allowed to rest for 2 min; (4) the sample
was then extended to 5 % strain at 1 %/s and held for 5 min, in
order to investigate the stress relaxation; and (5) finally, the
sample was tested to failure at 0.5 %/s.
The load-to-failure test was performed by increasing the
tensile load continuously with a speed of 10 mm/min. The
tensile load and elongation were recorded, and stiffness
was determined by the slope of the load–deformation
curve.
Histological evaluation
Two knee joints from each group were dissected into
patella–patellar tendon–tibial tuberosity complexes. The
complexes were fixed in 4 % paraformaldehyde and
embedded in paraffin. Transverse sections of 5 lm were
cut, collected on slides and stained with haematoxylin and
eosin (HE) for histological evaluation.
Statistical analysis
All data were analysed using SPSS 13.0 software, and
statistically significant differences were defined as
p \ 0.05. The mechanical properties were expressed as
mean ± standard deviation (SD). The difference was
detected using one-way analysis of variance (ANOVA)
test, and differences between individual test groups were
analysed by a post hoc Tukey’s pairwise multiple com-
parison procedure.
Results
Post-operative course
Sheep recovered well following surgery, the external
wound healed rapidly, and there were no infections. Sheep
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were able to rise and stand normally and regained full load
bearing on the operated leg at between 2 and 7 days.
Gross observation
The knee joint was exposed and carefully examined. No
signs of patellar osteoarthritis or synovial membrane
reactions were detected.
Scar tissue was present around patellar tendons of the
three operative groups, which had to be carefully removed
to expose the tendon/implant fibres. The presence of scar
tissue was slightly more abundant around implanted ten-
dons with respect to empty tendons. In the empty group at
both 3 and 6 months, the outer thirds of the tendon
appeared to be very close or in touch with one another with
almost no regenerated tissue in between (Fig. 3a, c, d). In
the EDC and EDC/EGDE groups at both 3 and 6 months,
the implant was always well recognizable in the centre of
the tendon and no gross resorption of the implant was
observed (Fig. 3b, e, f). Fat pad adhesion to the operative
site was always observed for both empty and implanted
defects.
The process of further dissecting the tendons in thirds
for mechanical testing was straightforward for the
implanted tendons, but was difficult for the empty group, in
that it was almost impossible to exclude native tendon
fibres from the dissection of the central third (Fig. 3d,
arrows).
Mechanical testing
When samples were tested to failure, the rupture always
occurred in the tendon mid-substance and bony avulsion
was never observed. The most part of the central third
samples failed neatly at a point within the tendon, and a
few implants were observed to fail near the bottom bone
block. Of the unoperated thirds, a large number failed by
some fibres pulling away from the bottom bone block and
some pulling away from the top bone block, and the others
failed neatly within the tendon.
The mechanical properties of the studied groups are
shown in Table 1. At the time of dissection, the two rem-
nant thirds of the empty group were often found to have
collapsed together (Fig. 3a). For this reason, the separation
procedure was difficult, and often native tendon fibres were
comprised in the sectioned central third (Fig. 3d). There-
fore, the results showed in Table 1 and in Fig. 4 (dotted
Fig. 2 Surgical procedure. a Paratenon was excised and preserved;
b patellar tendon central third was sectioned with a double-blade
knife; c two holes were drilled (arrows) at the insertion of the
dissected central third. The fat pad is clearly visible (asterisk)
between the outer thirds of the tendon; d two K-wires were driven
from the patella to the drilled hole (arrow) to allow implant suture
fixation. The same procedure was performed on the tibial side (not
shown); e implant fixation with sutures emerging from the drilled
bone holes; f implant tensioned in place; g three pairs of sutures were
placed at the boundary between implant and native tendon to facilitate
future dissection; h suture marks were placed in the empty group (fat
pad is visible within the two tendon remnants)
b
Fig. 3 a Empty sample (6 months) of whole patellar tendon from the
patella (top) to tibial tuberosity (bottom). b Implanted sample (EDC,
6 months). c Empty sample (3 months) whose patella and tendon
have been sectioned in thirds to perform mechanical testing. d Detail
of central third tendon to bone (patella) insertion. Arrows show native
tendon fibres in the central third, where only regenerated tissue should
be observed. e Implanted sample (EDC/EGDE, 3 months) sectioned
in thirds. f Detail of implant to bone (patella) insertion showing good
macroscopic integration. g, h Mechanical test setting: note the tibial
tuberosity inclination of 20 to allow even fibre tensioning
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line columns) have to be interpreted carefully. Stress to
failure and modulus of the empty group were significantly
lower than those of unoperated controls, but significantly
higher than those of both implants at each of the two time
points (Fig. 4b, h ampersand, dollar sign, pound sign
symbol). The strain to failure of the empty central thirds
was not statistically different from that of the implants and
of unoperated thirds at both time points.
The stress to failure of the implants was always statis-
tically lower than that of unoperated controls (Fig. 4b). The
EDC group had a stress to failure almost twice than that of
the EDC/EGDE group at both time points, but it was not
statistically significant (Fig. 4b). In the outer thirds
(Fig. 4a, c), all the operative groups at 3 months showed a
decrease in stress to failure with respect to unoperated
controls. However, all the operative groups except for
EDC/EGDE showed an increase (p [ 0.05) in stress to
failure from the 3- to the 6-month time point.
The strain to failure of the implants (Fig. 4e) was
slightly lower but never statistically different from that of
unoperated controls, with a slight, non-significant decrease
from 3 to 6 months (Fig. 4d, f). In the outer thirds, strain
to failure was never significantly different from that of
unoperated controls.
The modulus of the implants was always significantly
lower than that of the unoperated controls (Fig. 4h aster-
isk). Modulus of EDC implants was significantly greater
than that of EDC/EGDE implant at both 3- and 6-month
time point (Fig. 4h double dagger, section sign). In the
outer thirds (Fig. 4g, i), all the operative groups at
3 months showed a decrease in modulus with respect to
unoperated controls. However, all the operative groups but
EDC/EGDE showed a non-significant increase in modulus
(p [ 0.05) from 3- to 6-month time point.
When the in vivo force to failure of the implants at 3 and
6 months was compared with the force to failure of the
hydrated pre-implanted scaffold (Fig. 4j), a statistically
significant increase was detected between pre-implanted
EDC and implants at both 3 and 6 months. On the contrary,
there was a significant decrease in force to failure between
pre-implanted EDC/EGDE and implants at both 3 and
6 months.
Histological evaluation
At both 3 and at 6 months, the outer thirds of the patellar
tendon of the empty group were joined by a thin layer of
loose connective tissue rich in large vessels (Fig. 5c, i, l).
In one of the 6-month specimens (Fig. 5f), there is an
interposition of tissue which has a tendon-like appearance
and yet has a different morphology to the outer thirds,
being more cellular and with bundles that did not separate
during sectioning. It is possible that this is newly regen-
erating tendon tissue. All the implants (EDC and EDC/
EGDE) were clearly visible in the central third of the
patellar tendon. No gross resorption occurred at the
examined time points even though there appeared to be a
decrease in the number of fibres for the EDC implants with
respect to EDC/EGDE implants at both time points
(Fig. 5a, b, d, e). All the implants at both time points were
Table 1 Mechanical properties of bone–tendon–bone units
Mean stress (MPa) ± SD Mean strain (%) ± SD Mean modulus (MPa) ± SD Mean area (mm2)
3 months 6 months 3 months 6 months 3 months 6 months 3 months 6 months
Lateral thirds
EDC 15 ± 7 21 ± 15 18 ± 5 17 ± 4 125 ± 53 259 ± 62 23 ± 5*b 20 ± 4
EDC/EGDE 14 ± 6*b 14 ± 3*b 19 ± 2 18 ± 4 131 ± 58 118 ± 41 29 ± 9*b 17 ± 2
Empty 18 ± 6 26 ± 12 21 ± 4 20 ± 3 150 ± 38 253 ± 116 22 ± 6*b 18 ± 4
Control 30 ± 11*a 19 ± 3 222 ± 70 13 ± 2*a
Central thirds
EDC 3 ± 2*b,a 4 ± 2*b,§a 16 ± 3 15 ± 4 26 ± 15*b,a,%a 51 ± 22*b,§a,$a 23 ± 5*b,b 18 ± 4
EDC/EGDE 1 ± 1*b,a, 1 ± 1*b,§a 16 ± 5 14 ± 2 10 ± 4*b,b,%a 15 ± 10*b,§b,$a 25 ± 5*b,b 25 ± 5*b,b
Empty 8 ± 5b,%a 13 ± 6§b,%a 18 ± 5 15 ± 4 65 ± 28 %b,£a 141 ± 32$b,£a 19 ± 4b 11 ± 2a
Control 39 ± 12*a,%b 21 ± 2 293 ± 72*a,£b 14 ± 3*a
Medial thirds
EDC 7 ± 6*b 19 ± 6 17 ± 3 17 ± 3 73 ± 56 198 ± 63 30 ± 12 22 ± 7
EDC/EGDE 11 ± 5 13 ± 7 25 ± 6 18 ± 6 68 ± 41*b 115 ± 28 31 ± 5*b,b 23 ± 8
Empty 10 ± 6 25 ± 11 19 ± 4 19 ± 3 104 ± 52 241 ± 66 29 ± 5*b 21 ± 3a
Control 21 ± 8*a 20 ± 4 146 ± 45*a 16 ± 3*a
*a Significantly different from *b,a significantly different from b,§a significantly different from §b,%a significantly different from %b,$a signifi-
cantly different from $b,£a significantly different from £b (p \ 0.05). N = 6 for each group. SD standard deviation
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in close touch with the surrounding tendon; however, the
EDC samples appeared more integrated and with a higher
level of regenerated tissue between the fibres when com-
pared to the EDC/EGDE samples (Fig. 5d, e, g, h). The
regenerated tissue between the fibres appeared more cel-
lular and more vascular (Fig. 5g, j) than the normal tendon
tissue. It was mainly composed of tendon fibroblasts, with
a few polymorphonuclear cells and multinuclear cells
adhering on the fibres (Fig. 5k). In both groups, no
encapsulation of the implant occurred in contrast to the
encapsulation described by other authors [9, 15].
In the EDC group, a certain degree of fibre fragmentation
and resorption was observed at both 3 and 6 months (Fig. 5j);
in fact, in some cases the boundary between the collagen fibre
and the surrounding tissue was not clearly visible (Fig. 5j).
On the other hand in the EDC/EGDE group, a neat distinction
between the fibre and the tissue was always observed (Fig. 5h,
k). Interestingly, in the EDC group at both time points, tendon
fibroblasts often entered the interstices resulting from fibre
fragmentation (Fig. 5g) and just a few multinuclear cells
could be observed adhering on the fibres. On the contrary,
tendon fibroblasts rarely entered EDC/EGDE fibres, and
multinuclear cells could be observed adhering on the
periphery of the fibre itself (Fig. 5k). It is likely that many of
the empty spaces within the EDC/EGDE fibres are tissue
processing artefacts (Fig. 5h).
Fig. 4 Bar graphs illustrating tendon thirds/implants stress to failure
(a, b, c), strain to failure (d, e, f), modulus (g, h, i) and failure force
(j). Statistically significant difference (p \ 0.05) is highlighted by red
(asterisk symbol), blue (double dagger symbol), green (section sign
symbol), orange (ampersand symbol), light green (pound sign symbol)
and purple (dollar sign symbol) lines
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Discussion
The main findings of this study were the following: (1) the
open-array fibre scaffold designed for tendon regeneration
allowed tissue ingrowth and integration and avoided
implant encapsulation; (2) the EDC crosslinking method
adopted in this study did not yield a strength of the collagen
fibre comparable with native tendon and did not allow a
consistent fibre resorption at 6-month follow-up; and (3)
the EDC/EGDE crosslinking produced an inferior
mechanical performance of the implant compared to EDC
crosslinking, probably due to an even slower resorption
rate. These results are consistent with the view that, whilst
one of the functions of the open fibre array is to provide
space in the defect to allow new tissue ingrowth, it is also
going to slow down the healing process if it is not resorbed
as the new tissue is formed.
Even though substantial biomechanical differences
between EDC and EDC/EGDE implants were not found,
some interesting comparisons can be made. In particular,
the trend to the increase in modulus from 3- to 6-month
time point for the EDC implant suggests that some degree
of tissue ingrowth and maturation occurred. This is likely
to be associated with the resorption phenomena observed in
the histological sections. Similarly, the significant increase
in load to failure for the EDC group from the pre-implanted
condition to the latest time point (Fig. 4j) suggests that
load-bearing ECM deposition occurred between and in
place of the implant fibres (Fig. 5d).
In comparison, the EDC/EGDE implant, in which no
fibre resorption and tissue substitution were observed, did
not show increased mechanical properties from 3 to
6 months, but conversely had a statistically significant
decrease in load to failure from the pre-implanted condition
to the 6-month time point (Fig. 4j).This phenomenon is
likely to be linked to the high level of implant crosslinking
which can decrease implant–cell interactions and possibly
interfere with the implant resorption and substitution [10].
It is conceivable that if substitution does not take place, the
implant could undergo fatigue and fibre tearing which
would lead to the progressive weakening of the structure.
There was a decrease in stress to failure and modulus of
the outer thirds of the operated patellar tendon with respect
to unoperated controls at the 3-month time point (Fig. 4a,
c, g, i). This decrease in mechanical properties is a com-
mon finding in both small and large animal models and
depends on remodelling by resident tendon fibroblasts due
to increased load [14, 30]. This decrease resolved by
6 months for the EDC and empty groups, but not for the
EDC/EGDE group (Fig. 4a, c, g, i), which seemed to
consistently interfere with the strength recovery of the
outer thirds of the tendon. Since the mechanical properties
of the implant are too low to implicate stress shielding over
the remnants, a certain degree of local toxicity of the EDC/
EGDE fibres may be postulated.
The empty central thirds had stress to failure and
modulus significantly higher than those of EDC and EDC/
EGDE implants at both time points. Empty stress to failure
values were 21 and 33 % compared to unoperated controls
at 3 and 6 months, respectively. These values are in line
with other studies in the literature [17, 22]. However, since
the presence of native tendon fibres has been documented
(Fig. 3d), these results are difficult to interpret. Moreover,
histological sections of the empty group showed the pres-
ence of collapsed remnants and loose connective tissue
between them (Fig. 5 c, i, l), suggesting that the strength
detected may be an overestimation of the real condition.
However, there was histological evidence for tendon
regeneration in one of the specimens (Fig. 5f) and if
present in the tested samples may also have contributed to
the mechanical strength.
Kato et al. [15] substituted the rat Achilles tendon with
glutaraldehyde or EDC/dehydrothermal treatment (DHT)
crosslinked collagen fibres cast in a non-crosslinked col-
lagen matrix. At 12 months, the EDC/DHT implant was
completely resorbed and produced a yield strength of
22 MPa and a modulus of 41 MPa which were 60 and
22 % with respect to normal tendon. At the same time
point, the implant crosslinked with glutaraldehyde resulted
in fibrous encapsulation and only partially resorbed pro-
duced a yield strength of 22 MPa and a modulus of
192 MPa, which were 60 and 104 % with respect to normal
tendon. The same group of authors demonstrated that the
EDC/DHT implant was completely resorbed already by
10 weeks after implantation [13]. The fact that resorption
occurred as early as 10 weeks for the EDC/DHT group
Fig. 5 Histological samples showing cross-sections of operated
tendons. Orientation is described by upper-case letters: A anterior,
P posterior, M medial, L lateral. a EDC implant at 6-month time point
(6 m). Non-resorbed EDC fibres are evident in dark pink (arrow);
b EDG/EGDE implant (3 m). Non-resorbed EDC/EGDE fibres are
evident in dark pink (arrow); c empty group (6 m) showing loose
connective tissue between tendon remnants; d EDC implant (6 m)
showing EDC fibres (arrow) and good integration and regenerated
tissue deposition between fibres (asterisk); e EDC/EGDE implant
(6 m) showing EDC/EGDE fibres (arrow) and good integration but
scarce deposition of regenerated tissue between fibres; f empty group
(6 m) with tissue having the appearance of regenerated tissue between
the outer thirds (rt); g EDC implant (3 m) showing dense regenerated
tissue deposition between fibres (asterisk) and small vessels (arrows);
h EDC/EGDE implant (3 m) showing packed fibres with scarce tissue
deposition. The white spaces between fibres are artefacts from cutting
and possibly from shrinkage of the tissue; i empty group (3 m).
Dotted line highlights the boundary between native tendon (nt) and
regenerated tissue (rt) with fibroblasts randomly organized; j EDC
implant (3 m) showing fibre resorption and small vessels (arrows);
k EDC/EGDE implant (3 m) showing multinuclear cells adhering
onto the collagen fibre (arrows); l empty group (6 m) showing loose
connective tissue and a big vessel (arrow)
b
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may be explained by the adoption of the DHT treatment,
which has been shown to weaken the collagen structure [32].
Similar results were obtained when the same implants
were adopted to substitute canine ACL [9]. By 20 weeks,
the entire EDC/DHT crosslinked implant had been resorbed
and replaced by a crimped repair tissue which yielded to a
stress to failure (17 MPa) of about 35 % of that of normal
ACL (49 MPa). At the same time point, the glutaraldehyde
crosslinked implant was only partially resorbed and
encapsulated by fibrous tissue and inflammatory cells and
had a stress to failure (10 MPa) of about 20 % of that of
normal ACL. Interestingly in both these studies [9, 15], the
mechanical properties of the EDC/DHT implant consis-
tently improved from the pre-implant condition to the latest
time point, indicating that load-bearing matrix was being
deposited into the scaffold, whist the contrary happened for
the glutaraldehyde implant.
In the present study by 6 months, the EDC implant had a
stress to failure of 4 MPa (9 % of unoperated control) and the
EDC/EGDE implant had a stress to failure of 1 MPa (3.6 % of
unoperated control). Several factors may help to account for
the differences observed between these results and those of the
two models described above [9, 15]. Firstly, the Achilles and
ACL studies were substitution models, whilst we used an
augmentation model in which the stress shielding operated by
the remnants may have contributed to the lower implant
strength and new tissue formation. Secondly, the difference in
crosslinking chemistry, implant positioning (anatomical
place, intra- or extra-articular) and species used may all have
contributed to the differences in outcome.
It is intuitive that substitution devices are of more interest to
clinicians when compared with augmentation devices. In fact,
whilst reparable rotator cuff tears may be a potential appli-
cation for augmentation scaffolds [20, 23], irreparable cuff
tears, ACL tears and Achilles tendon tears with a large gap all
require substitution devices. The scaffold used in the present
study may bear loads that the human tendon withstands in
everyday life [10]; however, it would rupture at a higher level
of activity. Therefore, since we could not control the animal
activity levels or immobilize the hind limb in a cast for a long
time, we opted for a tendon augmentation model. Moreover,
the central third of the patellar tendon offered the possibility to
study tendon healing in a more favourable condition of vas-
cularity and load protection with respect to other intra-artic-
ular sites (ACL).
The present study had a number of limitations. Firstly,
the mechanical results of the empty group may have been
affected by the difficulties in dissecting the repair tissue
and therefore do not represent a reliable negative control.
However, this does not prevent the valid comparison of the
two implant materials. Secondly, in order to limit the
number of animals used, duplicates only were used in each
group for histological analysis. Thirdly, the tendon–bone
junction was deliberately not explored because this study
was designed to look at the tendon regeneration, and a
direct implant to bone insertion was not created.
In recent years, many different materials for tendon and
ligament tissue engineering have been proposed. Extra-
cellular matrix (ECM)-derived scaffolds have already been
introduced in clinical practice and are FDA approved as
augmentation devices [6, 19], but they have shown a
number of important limitations [1]. Knitted silk has shown
promising results in a large animal model for ligament
substitution [11]. Poly-lactide-co-glycolide (PLGA) and
polyglycolic (PGA) scaffolds were investigated in small
animal models for tendon substitution with good biome-
chanical results [3, 26]. However, despite extensive
research, the material with the right combination of
strength and biocompatibility has not been found.
Whilst collagen fibres can be crosslinked to produce
materials with different mechanical and biological prop-
erties [16], they share the same basic structure and carry
inherent limitations such as intrinsic weakness and the
difficulty of manufacturing a reproducible product [34]. If a
stronger fibre is required, a high level of crosslinking has to
be used, and the biological interactions between cells and
fibres will deteriorate accordingly [8]. The results of the
present study and of other studies in the literature [9, 15]
suggest that the right trade-off between strength and
resorbability may not exist for collagen-derived fibres for
both augmentative and substitutional approaches to tendon
and ligament repair. However, novel crosslinking chemis-
tries are being developed [16], and the association between
scaffolds, cell therapy and growth factors will possibly be
the key to overcome the shortcomings of collagen scaffolds
alone [19].
This study is clinically relevant because it demonstrated
that a scaffold made of an open array of fibres is easy to
handle and to deliver on surgical site and allows optimal
tissue regeneration and ingrowth.
Conclusion
The present study aimed to develop a fibrous collagen
implant for tendon and ligament biological augmentation.
The free fibres allowed good tendon–implant integration;
however, more efforts have to be made to produce implants
that combine good initial fibre strength with an optimal
resorption rate in order to favour prompt substitution of the
implant by regenerated tissue.
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